bq 610 has been researched along with atrial natriuretic factor in 1 studies
| Studies (bq 610) | Trials (bq 610) | Recent Studies (post-2010) (bq 610) | Studies (atrial natriuretic factor) | Trials (atrial natriuretic factor) | Recent Studies (post-2010) (atrial natriuretic factor) |
|---|---|---|---|---|---|
| 124 | 1 | 3 | 15,455 | 1,105 | 1,760 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gardner, DG; Glenn, DJ; Liang, F; Nishimoto, M; Rahmutula, D | 1 |
1 other study(ies) available for bq 610 and atrial natriuretic factor
| Article | Year |
|---|---|
Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism.
Topics: Animals; Animals, Newborn; Atrial Natriuretic Factor; Autocrine Communication; Binding Sites; Cell Proliferation; Cells, Cultured; Coculture Techniques; DNA Replication; Dose-Response Relationship, Drug; Down-Regulation; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; GATA4 Transcription Factor; Heart Ventricles; Myocytes, Cardiac; Oligopeptides; Paracrine Communication; Phosphorylation; Polysaccharides; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; RNA Interference; Serine; Signal Transduction; Transcriptional Activation; Transfection | 2009 |